Edition:
United Kingdom

People: Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

38.19USD
15 Nov 2018
Change (% chg)

$0.54 (+1.43%)
Prev Close
$37.65
Open
$37.41
Day's High
$38.26
Day's Low
$35.98
Volume
845,446
Avg. Vol
792,888
52-wk High
$111.36
52-wk Low
$33.52

Doberstein, Stephen 

Dr. Stephen K. Doberstein, Ph.D., is Senior Vice President, Research & Development and Chief Research & Development Officer of the Company. Dr. Doberstein served as Senior Vice President and Chief Scientific Officer from January 2010 to November 2017 when he was promoted to Senior Vice President, Research & Development and Chief Research & Development Officer. From October 2008 through December 2009, Dr. Doberstein served as Vice President, Research at Xoma (US) LLC, a publicly traded clinical stage biotechnology company. From July 2004 until August 2008, he served as Vice President, Research at privately held Five Prime Therapeutics, Inc., a clinical stage biotechnology company. From September 2001 until July 2004, Dr. Doberstein was Vice President, Research at privately held Xencor, Inc., a clinical stage biotechnology company. From 1997 to 2000, he held various pharmaceutical research positions at Exelixis, Inc. (Exelixis), a publicly traded clinical stage biotechnology company. Prior to working at Exelixis, Dr. Doberstein was a Howard Hughes Postdoctoral Fellow and a Muscular Dystrophy Association Senior Postdoctoral Fellow at the University of California, Berkeley. Dr. Doberstein received his Ph.D. in Biochemistry, Cell and Molecular Biology from the Johns Hopkins University School of Medicine and received a B.S. in Chemical Engineering from the University of Delaware.

Basic Compensation

Total Annual Compensation, USD 1,054,080
Restricted Stock Award, USD 2,958,790
Long-Term Incentive Plans, USD --
All Other, USD 3,686,070
Fiscal Year Total, USD 7,698,950

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 540,000 9,606,640.00
Name Fiscal Year Total

Robert Chess

556,763

Howard Robin

18,097,400

Gilbert Labrucherie

7,780,090

John Nicholson

7,831,160

Jillian Thomsen

--

Stephen Doberstein

7,698,950
As Of  31 Dec 2017